Health-Related Quality of Life for Patients Receiving Tumor Treating Fields for Glioblastoma
BackgroundTo date, there has been no large-scale, real-world study of the health-related quality of life outcomes for patients using tumor treating fields (TTFields) therapy for glioblastoma (GBM) treatment.MethodsA survey was mailed to 2,815 patients actively using TTFields for treatment of GBM in...
Guardado en:
Autores principales: | Joshua D. Palmer, Gordon Chavez, Wesley Furnback, Po-Ya Chuang, Bruce Wang, Christina Proescholdt, Chao-Hsiun Tang |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c221ce71a4484dd5b76a341b782eca83 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Real-world evidence data on the monoclonal antibody erenumab in migraine prevention: perspectives of treating physicians in Germany
por: Andreas Straube, et al.
Publicado: (2021) -
Identification of Differentially Expressed Genes in Different Glioblastoma Regions and Their Association with Cancer Stem Cell Development and Temozolomide Response
por: Justin Bo-Kai Hsu, et al.
Publicado: (2021) -
Demographics, Changes in Treatment Patterns, and Outcomes of Bone and Soft Tissue Sarcomas in Korea—A Sarcoma-Specific, Institutional Registry-Based Analysis
por: Jeong H, et al.
Publicado: (2021) -
Interstitial Photodynamic Therapy for Glioblastomas: A Standardized Procedure for Clinical Use
por: Henri-Arthur Leroy, et al.
Publicado: (2021) -
A Prospective, Observational Registry Study to Evaluate Effectiveness and Safety of Hyaluronic Acid-Based Dermal Fillers in Routine Practice: Interim Analysis Results with One Year of Subject Follow-Up
por: Bhojani-Lynch T, et al.
Publicado: (2021)